semaglutide skinnyrx The Next Generation of GLP-1 Weight Loss Medication is a Daily Tablet SkinnyRx: GLP-1 Weight Loss Telemedicine

GLP-1/GIP chimeric peptides capable of activating both receptors have shown remarkable weight-losing and glucose-lowering efficacy in obese individuals with T2D

In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD discusses how semaglutide became the first FDA-approved oral GLP-1 agonist for obesity

Potentially higher bioavailability than oral supplements

Reconstituted peptides should be aliquoted, refrigerated or frozen appropriately, and protected from repeated freeze-thaw cycles

Compounded Compounded GLP-1 medications are the most affordable option in this entire category